Sept. 24 (UPI) -- The Centers for Disease Control and Prevention late Thursday approved a third dose of the Pfizer COVID-19 vaccine for Americans over 65 -- and for younger people who are at increased risk of infection due to their profession.
The decision makes available a third dose of Pfizer's vaccine to tens of millions of Americans six months after they receive the second shot.